Company Profile · Healthcare

Tibet Rhodiola Pharmaceutical Holding Co

600211 · Shanghai
Country
China
IPO date
Jul 1, 1999
Employees
671
Buffett Score
72/100
Strong
Market capCN¥11.72B
Revenue (TTM)CN¥2.89B
EBITDACN¥884.19M
Profit margin33.92%
ROE21.79%
P/E (TTM)11.88
Forward P/E135.14
EPSCN¥3.06
Dividend yield5.65%
52-week rangeCN¥34.80 – CN¥49.94

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

Tibet Rhodiola Pharmaceutical Holding Co. produces and sells pharmaceutical products in China and internationally. The company offers modern Tibetan Medicines, including Nodikang capsules and granules, snow mountain golden arhat pain relief film, and ten-flavor Tida capsules; modern Chinese medicines, such as children Shuangqing granules, lipid clearing capsules, ginseng and zhi capsules, puyu capsules, and epilepsy flat film; and recombinant human brain natriuretic peptide for injection. It also provides isosorbide mononitrate sustained-release tablets; and oxygen rhodiola rosea moisturizing essence, secret recipe fragrance powder packet, rhodiola rosea, and Yuan Yang rhodiola rosea moisturizing essence products. In addition, the company offers biopharmaceuticals, traditional Chinese medicine, and chemical drugs for various fields, such as cardiovascular and cerebrovascular diseases, hepatobiliary diseases, orthopedic pain relief, rheumatism, and cold medicines. The company was founded in 1999 and is headquartered in Lhasa, China.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

No reports on this stock in your language yet.